Biased Ligands. Better Drugs.

APS - APOLLO-1: TRV130 Bunionectomy Trial

APOLLO-1: A Randomized, Placebo- and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a Novel μ Receptor G Protein Pathway Selective (μ-GPS) Modulator, for Management of Moderate to Severe Acute Pain Following Bunionectomy

F Skobieranda, N Singla, DA Burt, DG Soergel

View PDF

Copyright © Trevena, Inc.